Literature DB >> 66475

Plasma-myoinositol concentrations in uraemic neuropathy.

R H Reznek, J G Salway, P K Thomas.   

Abstract

In a series of patients with chronic renal failure managed conservatively, the rise in the plasma-myo-inositol (myoinositol) concentration has been found to be related to depression of sural-nerve conduction velocity. There was no correlation with motor-nerve conduction velocity in the peroneal nerve, or with either of these variables in a series of patients receiving chronic haemodialysis. Despite the negative correlation with sural-nerve conduction velocity, there was no correlation between the plasma-myoinositol concentration and the presence of peripheral neuropathy as assessed clinically. It is concluded that hypermyoinositolaemia may depress nerve conduction velocity, but there is no evidence that it is responsible for the development of uraemic polyneuropathy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66475     DOI: 10.1016/s0140-6736(77)92116-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

1.  [Effect of hemodialysis on somatosensory evoked potentials in uremia patients].

Authors:  G Niemann; M Stöhr; G A Müller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

2.  Influence of dietary myoinositol on nerve conduction and inositol phospholipids in normal and diabetic rats.

Authors:  J G Jefferys; K P Palmano; A K Sharma; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-04       Impact factor: 10.154

3.  Refractory period, sensory conduction velocity and visual evoked potentials before and after haemodialysis.

Authors:  K Lowitzsch; U Göhring; E Hecking; H Köhler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.